2026-06-01T11:42:02Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ijcem.000053 2021-09-24 PTZ.IJCEM:VOL7

Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients? YRKM Sai<p>Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1].&nbsp;</p> International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications 2021-09-24 Perspective Study https://doi.org/10.17352/ijcem.000053 en Copyright © YRKM Sai et al.